CONCORD HC GP Reports 2025 Results: Net Loss Attributable to Shareholders Narrows 42.1% to RMB 257 Million
Stock News
Mar 27
CONCORD HC GP (02453) announced its annual results for the year ended December 31, 2025. Revenue reached RMB 460 million, representing a year-on-year increase of 18.4%. The loss attributable to company owners was RMB 257 million, narrowing by 42.1% compared to the previous year. The basic loss per share was RMB 0.34. During the period, revenue from the hospital business increased by 37.4% year-on-year to RMB 373.3 million in 2025, primarily driven by significant growth in revenue from the proton therapy business at the Guangzhou hospital.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.